PMID- 16767476
OWN - NLM
STAT- MEDLINE
DCOM- 20070501
LR  - 20181113
IS  - 0020-9554 (Print)
IS  - 0020-9554 (Linking)
VI  - 47
IP  - 6
DP  - 2006 Jun
TI  - [Lung cancer].
PG  - 611-20; quiz 621
AB  - Although various benign and malignant tumors can occur in the bronchi and lungs, 
      lung cancer is by far the most common tumor and the leading cause of tumor death 
      worldwide. For therapeutic reasons lung cancer is classified currently as small 
      cell (SCLC) or non small cell lung cancer (NSCLC). The main cause is smoking. 
      There are no specific symptoms that enable early detection. Staging is according 
      to the international TNM-system. As the results of therapy to date are 
      disappointing and many questions remain unsolved, as many patients as possible 
      should be included in further prospective trials. In SCLC polychemotherapy is 
      mandatory; in local tumor stages radiotherapy should be combined early on with 
      chemotherapy, and in cases of complete remission, prophylactic cranial 
      irradiation is indicated. In operable stages of NSCLC adjuvant chemotherapy 
      demonstrates a survival benefit. In locally advanced NSCLC, radiochemotherapy is 
      now the standard of care. Advanced stages require chemotherapy usually with two 
      drugs, second-line chemotherapy is indicated in cases of relapse.
FAU - Huber, R M
AU  - Huber RM
AD  - Pneumologie, Klinikum der Universitat - Innenstadt, Ziemssenstrasse 1, 80336 
      Munchen, Germany. pneumologie@med.uni-muenchen.de
LA  - ger
PT  - English Abstract
PT  - Journal Article
PT  - Review
TT  - Lungenkarzinom.
PL  - Germany
TA  - Internist (Berl)
JT  - Der Internist
JID - 0264620
SB  - IM
MH  - Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
MH  - Clinical Trials as Topic/trends
MH  - Combined Modality Therapy
MH  - Drug Therapy/*trends
MH  - Humans
MH  - Lung Neoplasms/*diagnosis/*therapy
MH  - Practice Guidelines as Topic
MH  - Practice Patterns, Physicians'/trends
MH  - Radiotherapy/*trends
MH  - Treatment Outcome
RF  - 16
EDAT- 2006/06/13 09:00
MHDA- 2007/05/02 09:00
CRDT- 2006/06/13 09:00
PHST- 2006/06/13 09:00 [pubmed]
PHST- 2007/05/02 09:00 [medline]
PHST- 2006/06/13 09:00 [entrez]
AID - 10.1007/s00108-006-1581-3 [doi]
PST - ppublish
SO  - Internist (Berl). 2006 Jun;47(6):611-20; quiz 621. doi: 
      10.1007/s00108-006-1581-3.